Q: Please describe this drug.
Description: The Compound can be represented with the SMILES CCCCOc1ccc(CC(=O)NO)cc1.
Result: Bufexamac is a non-steroidal anti-inflammatory drug (NSAID) under the market name Droxaryl, Malipuran, Paraderm and Parfenac. It is typically administered topically for the treatment of subacute and chronic eczema of the skin, including atopic eczema and other inflammatory dermatoses, as well as sunburn and other minor burns, and itching. It has also been used in suppositories in combination with local anaesthetics indicated for haemorrhoids. The use of bufexamac has been discontinued in Canada and the United States, which may be due to undetermined clinical efficacy and a high prevalence of contact sensitization. Bufexamac was also withdrawn by the EMA in April 2010.
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
CCCCOc1ccc(CC(=O)NO)cc1
CCCCOC1=CC=C(C=C1)CC(=O)NO
2-(4-butoxycyclohexa-1,3,5-trien-1-yl)-N-hydroxyacetamide
Please describe this drug.